Effectiveness of once daily meropenem for the treatment of aspiration pneumonia of elderly patients in long-term care facilities Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP Source: Eur Respir J 2013; 41: 123-130 Year: 2013
Switch from intravenous to oral antibiotic therapy in hospitalized patients with non-severe community acquired pneumonia Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections Year: 2010
An evaluation of the safety, efficacy and cost-effectiveness for patients with acute respiratory illness, of a community-based intravenous medication service: The first 26 months Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care Year: 2011
Reducing unnecessary antibiotic use and hospitalization in children with pneumonia Source: International Congress 2019 – Epidemiology of childhood respiratory diseases Year: 2019
A community-based intravenous medication service has proven to be safe, effective and cost-effective for patients with acute respiratory illness Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine Year: 2010
The efficacy of antiviral therapy of acute respiratory infections in paediatric practice Source: International Congress 2017 – New insights into paediatric respiratory infections Year: 2017
Pharmacoepidemiology of antibiotics using for treatment severe pulmonary infections in a clinical city hospital Source: Eur Respir J 2005; 26: Suppl. 49, 640s Year: 2005
Long-term benefits of antibiotic treatment in reducing recurrence rates and resource utilization in acute exacerbations of chronic bronchitis (AECB) Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003
Oral health care prevents respiratory infection in bed-ridden and tube-feeding patients with recurrent pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 189s Year: 2005
Effectiveness of empirical treatment of community acquired pneumonia requiring hospitalization Source: Eur Respir J 2006; 28: Suppl. 50, 166s Year: 2006
CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions Source: Eur Respir J, 53 (5) 1802014; 10.1183/13993003.02014-2018 Year: 2019
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019 Year: 2019
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019 Year: 2019
Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Initial intravenous antibiotic regimen in patients hospitalized for community acquired pneumonia (CAP) in France Source: Eur Respir J 2003; 22: Suppl. 45, 151s Year: 2003
Costs of treatment of hospitalised community-acquired pneumonia from the hospitals’ perspective – a prospective study comparing moxifloxacin with other antibiotic treatment alternatives Source: Eur Respir J 2004; 24: Suppl. 48, 185s Year: 2004
Integrated care pathways significantly reduce drug dosing and administration errors in patients with acute asthma Source: Eur Respir J 2006; 28: Suppl. 50, 481s Year: 2006
A comparison of intravenous versus oral administration of corticosteroids in the treatment of patients admitted to the hospital with an exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 64s Year: 2004
Antibiotic prescribing in acute respiratory infections – are we following guidelines? Source: Eur Respir J 2006; 28: Suppl. 50, 349s Year: 2006